期刊文献+

医护人员乙型肝炎病毒感染现况调查及防护 被引量:2

Prevalence survey and protection of hepatitis B virus infection in medical staffs
下载PDF
导出
摘要 目的:分析医务人员乙型肝炎病毒(HBV)感染的流行病学特点,探讨有效的控制策略。方法:对448名临床医务人员和256名非临床人员进行HBV血清流行病学调查。结果:内、外科医务人员HBV感染率分别为82.8%和87.7%,高于非临床人员的73.4%(P<0.05);护士组HBV感染率高于医生组(P<0.05),其中外科护士HBV感染率为90.5%,远高于外科医生的80.0%(P<0.05)。结论:综合性医院乙型肝炎(乙肝)的防治对象是一线临床医务人员,且重点为外科护士,控制策略为三级预防。 Objective:To investigate the epidemiological characteristics of hepatitis B virus (HBV) infection in medical staffs,so as to study the effective measures to control the HBV infection.Methods:The enzyme-linked immunosorbent assay(ELIA) was applied to examine the serous samples from 448 medical staffs and 256 non-medical staffs.Results:The infection rate of HBV in the medical department group and the surgical group was 82.8% and 87.7% respectively and higher than 73.4% in the non-medical staff group (P〈0.05).The in- fection rate of HBV in the nurse group was higher than that in the doctor group (P〈0.05),in which the infection rate in the surgical nurses was 90.5%,and significantly higher than 80.0% in the surgeons(P〈0.05).Conclusion : The medical staffs should be proteeted from the HBV infection in general hospital,in which the protection of surgical nurses is emphatieal.Comprehensive prevention is the effective measure to control the HBV infection.
作者 黄欣淳
出处 《现代医药卫生》 2007年第11期1612-1613,共2页 Journal of Modern Medicine & Health
关键词 乙型肝炎 病毒 干预 Hepatitis B Virus Intervention
  • 相关文献

参考文献1

二级参考文献10

  • 1Lai CL, Chiem RN, Leung NWY,et al. A one-year trial of lamivudine for chronic hepatitis B[J]. Hepatology,1998,339:61-68
  • 2Marinos G, Scaglioni NV, Willians R, et al. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B infection[J]. Hepatology,1996,24:991-995
  • 3Severin A, Liu XY, Wilson JS, et al. Mechanism of duck hepatitis B virus polymerase by (1)-L-2′,3′-dideoxy-3′-thiacytdine[J].Antimicrob Agents Chemother,1995,39:1430-1435
  • 4Boni C, Bertoletti A, Penna A, et al. Lamivodine treatment can restore T cell responsiveness in chronic hepatitis B[J]. J Clin Invest, 1998,102:968-975
  • 5Schiff ER, Karayalcin S, Grimm L, et al. Aplacebo controlled study of lamivudine and interferon α-2b in patients with chronic hepatitis B who previously failed interferon therapy[J]. Hepatology,1998,28:388A(Abstract 901)
  • 6Marrinos G, Scaglioni NV, Williams R, et al. Inpact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B infection[J]. Hepatology,1996,24:991-995
  • 7Multimer D, Naoumov NV, Honkoop P, et al. combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection:Result of a pilot study[J]. J Hepatol,1998,28:923-920
  • 8刘崇柏.我国病毒性肝炎人群流行病学特征及流行因素研究[J].中华肝脏病杂志,1998,6(2):67-70. 被引量:139
  • 9费筠华,秦来英,范桂玲,阚晓.干扰素α联合拉米夫定治疗慢性乙型肝炎临床观察[J].山东医药,1999,39(11):3-4. 被引量:6
  • 10王耀宗.慢性乙型肝炎抗病毒治疗药物—拉米夫定的临床应用[J].山东医药,1999,39(11):41-43. 被引量:1

共引文献1

同被引文献15

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部